Teleflex Incorporated (NYSE:TFX) Shares Acquired by Quantbot Technologies LP

Quantbot Technologies LP lifted its holdings in Teleflex Incorporated (NYSE:TFX) by 877.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 23,228 shares of the medical technology company’s stock after acquiring an additional 20,852 shares during the quarter. Quantbot Technologies LP’s holdings in Teleflex were worth $4,886,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. grew its position in Teleflex by 1.8% during the 1st quarter. Vanguard Group Inc. now owns 5,550,727 shares of the medical technology company’s stock worth $1,255,408,000 after purchasing an additional 96,711 shares during the period. Janus Henderson Group PLC grew its holdings in Teleflex by 12.0% during the first quarter. Janus Henderson Group PLC now owns 5,409,317 shares of the medical technology company’s stock worth $1,223,424,000 after acquiring an additional 581,312 shares during the period. Wellington Management Group LLP raised its position in Teleflex by 2.1% during the fourth quarter. Wellington Management Group LLP now owns 2,496,566 shares of the medical technology company’s stock valued at $622,494,000 after acquiring an additional 52,533 shares in the last quarter. Cooke & Bieler LP lifted its holdings in Teleflex by 23.3% in the second quarter. Cooke & Bieler LP now owns 912,797 shares of the medical technology company’s stock valued at $191,989,000 after acquiring an additional 172,335 shares during the period. Finally, Norges Bank purchased a new stake in Teleflex in the 4th quarter worth approximately $118,665,000. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Insider Activity at Teleflex

In other Teleflex news, Director Stuart A. Randle sold 2,674 shares of the firm’s stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $238.93, for a total value of $638,898.82. Following the transaction, the director now directly owns 5,496 shares of the company’s stock, valued at approximately $1,313,159.28. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 1.43% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the stock. Stephens lifted their target price on shares of Teleflex from $275.00 to $290.00 and gave the company an “overweight” rating in a report on Friday, August 2nd. Piper Sandler upgraded shares of Teleflex from a “neutral” rating to an “overweight” rating and upped their price objective for the stock from $205.00 to $245.00 in a research report on Monday, July 1st. Truist Financial increased their target price on shares of Teleflex from $240.00 to $247.00 and gave the stock a “hold” rating in a research note on Monday, August 5th. Finally, Royal Bank of Canada lifted their price target on Teleflex from $235.00 to $260.00 and gave the company an “outperform” rating in a research note on Friday, August 2nd. Three equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, Teleflex currently has an average rating of “Moderate Buy” and a consensus target price of $265.57.

Teleflex Trading Up 1.4 %

Shares of Teleflex stock opened at $246.05 on Monday. The company has a current ratio of 2.58, a quick ratio of 1.44 and a debt-to-equity ratio of 0.36. Teleflex Incorporated has a twelve month low of $177.63 and a twelve month high of $257.85. The firm has a market capitalization of $11.59 billion, a PE ratio of 39.49, a P/E/G ratio of 2.20 and a beta of 1.16. The firm’s 50-day moving average price is $232.92 and its 200 day moving average price is $219.78.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, August 1st. The medical technology company reported $3.42 earnings per share for the quarter, beating the consensus estimate of $3.33 by $0.09. Teleflex had a return on equity of 14.51% and a net margin of 8.76%. The business had revenue of $749.70 million for the quarter, compared to the consensus estimate of $762.98 million. During the same quarter last year, the business posted $3.41 earnings per share. The business’s quarterly revenue was up .9% compared to the same quarter last year. On average, sell-side analysts predict that Teleflex Incorporated will post 13.97 EPS for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, September 16th. Stockholders of record on Thursday, August 15th will be given a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.55%. The ex-dividend date of this dividend is Thursday, August 15th. Teleflex’s dividend payout ratio (DPR) is 21.83%.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.